
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
- Analyst Ratings
Upturn AI SWOT
- About
P3 Health Partners Inc (PIII)



- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)


(see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
04/22/2025: PIII (1-star) is currently NOT-A-BUY. Pass it for now.
Analysis of Past Performance
Type Stock | Historic Profit 155.42% | Avg. Invested days 27 | Today’s Advisory PASS |
Upturn Star Rating ![]() ![]() | Upturn Advisory Performance ![]() | Stock Returns Performance ![]() |
![]() ![]() | ![]() ![]() |
Key Highlights
Company Size Mid-Cap Stock | Market Capitalization 3.75B USD | Price to earnings Ratio - | 1Y Target Price 16.25 |
Price to earnings Ratio - | 1Y Target Price 16.25 | ||
Volume (30-day avg) 18212 | Beta 0.95 | 52 Weeks Range 7.00 - 40.50 | Updated Date 04/25/2025 |
52 Weeks Range 7.00 - 40.50 | Updated Date 04/25/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -54 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -9.05% | Operating Margin (TTM) -35.19% |
Management Effectiveness
Return on Assets (TTM) -24.23% | Return on Equity (TTM) -106.44% |
Valuation
Trailing PE - | Forward PE - | Enterprise Value 158347305 | Price to Sales(TTM) 2.5 |
Enterprise Value 158347305 | Price to Sales(TTM) 2.5 | ||
Enterprise Value to Revenue 0.11 | Enterprise Value to EBITDA -1.86 | Shares Outstanding 3263190 | Shares Floating 1141791 |
Shares Outstanding 3263190 | Shares Floating 1141791 | ||
Percent Insiders 61.91 | Percent Institutions 13.53 |
Analyst Ratings
Rating 4 | Target Price 31.25 | Buy - | Strong Buy 2 |
Buy - | Strong Buy 2 | ||
Hold 2 | Sell - | Strong Sell - | |
Strong Sell - |
Upturn AI SWOT
P3 Health Partners Inc
Company Overview
History and Background
P3 Health Partners Inc. was founded in 2016. It focuses on population health management and value-based care for seniors.
Core Business Areas
- Value-Based Care: Provides coordinated care through a network of primary care physicians and specialists, focusing on preventive care and chronic disease management.
- Risk-Bearing Partnerships: Partners with health plans and provider groups to manage the health of their members under risk-based contracts.
- Data Analytics and Technology: Utilizes data analytics and technology platforms to identify high-risk patients, improve care coordination, and optimize healthcare delivery.
Leadership and Structure
Dr. Sherif Abdou is the current CEO. The organizational structure includes teams focused on clinical operations, network management, data analytics, and finance.
Top Products and Market Share
Key Offerings
- P3 Care Model: A comprehensive care delivery model that integrates primary care, specialty care, and care management services. Market share is difficult to ascertain precisely, but P3 operates in a competitive landscape with rivals such as Oak Street Health (OSH) and Agilon Health (AGL). Focuses on Medicare Advantage patients.
- Network of Providers: A network of affiliated primary care physicians and specialists who deliver care to P3's patients. Revenue tied to contracts with health plans and provider groups.
- Data Analytics Platform: Their proprietary software to manage patient data. Competitors in the Healthcare analytics field include Cerner (now Oracle) and Allscripts.
Market Dynamics
Industry Overview
The healthcare industry is shifting towards value-based care models, driven by rising healthcare costs and a focus on improving patient outcomes. The Medicare Advantage market is growing rapidly.
Positioning
P3 Health Partners is positioned as a leader in the value-based care space, particularly for seniors. The company differentiates itself through its integrated care model and focus on data analytics.
Total Addressable Market (TAM)
The TAM for value-based care is estimated to be in the hundreds of billions of dollars, driven by the growing Medicare Advantage market. P3 is positioned to capture a significant share of this market through its expansion into new geographies and partnerships.
Upturn SWOT Analysis
Strengths
- Integrated care model
- Strong network of providers
- Data analytics capabilities
- Focus on value-based care
Weaknesses
- Relatively small size compared to competitors
- Geographic concentration in certain markets
- Dependence on key partnerships
Opportunities
- Expansion into new geographic markets
- Partnerships with additional health plans and provider groups
- Growth of the Medicare Advantage market
- Acquisition of smaller value-based care providers
Threats
- Increased competition from larger players
- Changes in healthcare regulations
- Economic downturn
- Inability to retain providers in their network
Competitors and Market Share
Key Competitors
- OSH
- AGL
- CHE
- HUM
Competitive Landscape
P3 Health Partners faces intense competition from larger, more established players. It attempts to distinguish itself with its integrated approach.
Major Acquisitions
Growth Trajectory and Initiatives
Historical Growth: Past growth has been marked by geographic expansion and increased partnerships. Review past annual reports for growth statistics.
Future Projections: Analyst projections depend on the company's strategic initiatives and financial performance. Check financial news outlets for updated analyst estimates.
Recent Initiatives: Focus on technology integration, network expansion, and cost management are key initiatives. News releases will be helpful.
Summary
P3 Health Partners operates in a competitive value-based care market. While their integrated approach and data analytics offer advantages, smaller size and geographic concentration present challenges. Future success depends on strategic expansion and strong partnerships, but with low market share, and an aggressive growth market, it's a high risk, high reward stock. Overall, P3 Health Partners operates in a competitive market and faces challenges related to its size and geographic concentration, making it a speculative investment.
Similar Companies
AGL

agilon health Inc


AGL

agilon health Inc
CHE

Chemed Corp


CHE

Chemed Corp

HUM

Humana Inc



HUM

Humana Inc

UNH

UnitedHealth Group Incorporated



UNH

UnitedHealth Group Incorporated
Sources and Disclaimers
Data Sources:
- Company Website
- SEC Filings
- Market Research Reports
- Financial News Outlets
Disclaimers:
The information provided is for informational purposes only and should not be considered financial advice. Market share data is approximate and may vary based on source. Always consult with a qualified financial advisor before making any investment decisions.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About P3 Health Partners Inc
Exchange NASDAQ | Headquaters Henderson, NV, United States | ||
IPO Launch date 2021-04-06 | CEO & President Dr. Aric Coffman M.D. | ||
Sector Healthcare | Industry Medical Care Facilities | Full time employees 360 | Website https://p3hp.org |
Full time employees 360 | Website https://p3hp.org |
P3 Health Partners Inc., a patient-centered and physician-led population health management company, provides superior care services in the United States. The company operates clinics and wellness centers. P3 Health Partners Inc. was founded in 2020 and is based in Henderson, Nevada.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.